[{"address1": "221 Crescent Street", "address2": "Building 17 Suite 102b", "city": "Waltham", "state": "MA", "zip": "02453", "country": "United States", "phone": "650 394 5230", "website": "https://www.apogeetherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs comprise APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 196, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael Thomas Henderson M.D.", "age": 34, "title": "CEO & Director", "yearBorn": 1990, "fiscalYear": 2023, "totalPay": 1171208, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jane Pritchett V. Henderson", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 843643, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Carl Linden Dambkowski M.D.", "age": 39, "title": "Chief Medical Officer", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 870833, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Noel  Kurdi", "title": "Vice President of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew  Batters J.D.", "age": 48, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1976, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Emily  Cox", "title": "VP & Head of People", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rebecca  Dabora Ph.D.", "age": 64, "title": "Chief Development Officer", "yearBorn": 1960, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Wendy  Aspden-Curran", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Drew  Badger Ph.D.", "title": "Senior VP and Head of Regulatory Affairs & Toxicology", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Monica  Forbes", "age": 48, "title": "Senior Vice President of Finance", "yearBorn": 1976, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 10, "overallRisk": 9, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 35.44, "open": 35.57, "dayLow": 35.13, "dayHigh": 37.3, "regularMarketPreviousClose": 35.44, "regularMarketOpen": 35.57, "regularMarketDayLow": 35.13, "regularMarketDayHigh": 37.3, "payoutRatio": 0.0, "forwardPE": -9.510527, "volume": 1256123, "regularMarketVolume": 1256123, "averageVolume": 564033, "averageVolume10days": 766410, "averageDailyVolume10Day": 766410, "bid": 35.97, "ask": 36.43, "bidSize": 2, "askSize": 2, "marketCap": 2099278592, "fiftyTwoWeekLow": 29.1, "fiftyTwoWeekHigh": 72.29, "fiftyDayAverage": 39.3188, "twoHundredDayAverage": 46.129677, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1590455040, "profitMargins": 0.0, "floatShares": 39063167, "sharesOutstanding": 44600700, "sharesShort": 8321096, "sharesShortPriorMonth": 8502020, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.1462, "heldPercentInsiders": 0.113900006, "heldPercentInstitutions": 1.30162, "shortRatio": 16.11, "shortPercentOfFloat": 0.2152, "impliedSharesOutstanding": 58087400, "bookValue": 12.345, "priceToBook": 2.927501, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -182146000, "trailingEps": -3.3, "forwardEps": -3.8, "enterpriseToEbitda": -7.34, "52WeekChange": -0.45424342, "SandP52WeekChange": 0.12744582, "quoteType": "EQUITY", "currentPrice": 36.14, "targetHighPrice": 116.0, "targetLowPrice": 80.0, "targetMeanPrice": 93.71429, "targetMedianPrice": 90.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 520652992, "totalCashPerShare": 8.963, "ebitda": -216680992, "totalDebt": 11831000, "quickRatio": 18.395, "currentRatio": 18.547, "debtToEquity": 1.651, "returnOnAssets": -0.23464, "returnOnEquity": -0.33216998, "freeCashflow": -113415752, "operatingCashflow": -171174000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "APGE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Apogee Therapeutics, Inc.", "longName": "Apogee Therapeutics, Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1741385669, "regularMarketTime": 1741381201, "exchange": "NGM", "messageBoardId": "finmb_1816591253", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.9751714, "regularMarketPrice": 36.14, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1689341400000, "postMarketChangePercent": 0.138349, "postMarketPrice": 36.19, "postMarketChange": 0.0499992, "regularMarketChange": 0.70000076, "regularMarketDayRange": "35.13 - 37.3", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 564033, "fiftyTwoWeekLowChange": 7.039999, "fiftyTwoWeekLowChangePercent": 0.24192436, "fiftyTwoWeekRange": "29.1 - 72.29", "fiftyTwoWeekHighChange": -36.15, "fiftyTwoWeekHighChangePercent": -0.5000692, "fiftyTwoWeekChangePercent": -45.424343, "earningsTimestamp": 1740999900, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.3, "epsForward": -3.8, "epsCurrentYear": -5.10333, "priceEpsCurrentYear": -7.0816503, "fiftyDayAverageChange": -3.1788025, "fiftyDayAverageChangePercent": -0.08084688, "twoHundredDayAverageChange": -9.989677, "twoHundredDayAverageChangePercent": -0.21655641, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-07-14", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "displayName": "Apogee Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]